Drug Trial Radar · NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
468
Planned (sponsor's estimate)
Start
Nov 25, 2025
Primary completion
Jun 2029
Study completion Jan 2031
Sponsor
- Lead sponsor
- Syndax PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain genetic mutations compared to chemotherapy alone. The study will also assess the safety of adding revumenib to chemotherapy.
Conditions
- Acute Myeloid Leukemias
Interventions
RevumenibDrug
Participants will receive revumenib orally.
PlaceboDrug
Participants will receive placebo (non-active agent) orally.
Intensive Chemotherapy RegimenDrug
Participants will receive an intensive chemotherapy regimen of cytarabine and daunorubicin by intravenous (IV) infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event Free SurvivalTime frame: Up to 2 years
- Measurable Residual Disease Complete Remission RateTime frame: Up to 2 years
Locations
173 sites in 23 countries. Site status is shown where the registry gives one.
Clinical Trial Site
Goodyear, Arizona · Recruiting
Clinical Trial Site
Duarte, California · Recruiting
Clinical Trial Site
Farmington, Connecticut · Recruiting
Clinical Trial Site
Tampa, Florida · Recruiting
Clinical Trial Site
Indianapolis, Indiana · Recruiting
Clinical Trial Site
Shreveport, Louisiana · Recruiting
Clinical Trial Site
Morristown, New Jersey · Recruiting
Clinical Trial Site
Chapel Hill, North Carolina · Recruiting
Clinical Trial Site
Providence, Rhode Island · Recruiting
Clinical Trial Site
Greenville, South Carolina · Recruiting
Clinical Trial Site
Houston, Texas · Recruiting
Clinical Trial Site
Buenos Aires, Argentina · Recruiting
Clinical Trial Site
Salta, Argentina · Recruiting
Clinical Trial Site
Adrogué, Buenos Aires, Argentina · Recruiting
Clinical Trial Site
Buenos Aires, Buenos Aires F.D., Argentina · Recruiting
Clinical Trial Site
Córdoba, Córdoba Province, Argentina · Recruiting
Clinical Trial Site
Gosford, Australia · Recruiting
Clinical Trial Site
Wollongong, Australia · Recruiting
Clinical Trial Site
Kingswood, New South Wales, Australia · Recruiting
Clinical Trial Site
Kogarah, New South Wales, Australia · Recruiting
Clinical Trial Site
Randwick, New South Wales, Australia · Recruiting
Clinical Trial Site
Douglas, Queensland, Australia · Recruiting
Clinical Trial Site
South Brisbane, Queensland, Australia · Recruiting
Clinical Trial Site
Melbourne, Victoria, Australia · Recruiting
Clinical Trial Site
Parkville, Victoria, Australia · Recruiting
Clinical Trial Site
Nedlands, Western Australia, Australia · Recruiting
Clinical Trial Site
Perth, Western Australia, Australia · Recruiting
Clinical Trial Site
Linz, Austria · Recruiting
Clinical Trial Site
Vienna, Austria · Recruiting
Clinical Trial Site
Klagenfurt, Kaerten, Austria · Recruiting
Clinical Trial Site
Sankt Pölten, Lower Austria, Austria · Recruiting
Clinical Trial Site
Graz, Styria, Austria · Recruiting
Clinical Trial Site
Leoben, Styria, Austria · Recruiting
Clinical Trial Site
Innsbruck, Tyrol, Austria · Recruiting
Clinical Trial Site
Ghent, Belgium · Recruiting
Clinical Trial Site
Jaú, Brazil · Recruiting
Clinical Trial Site
Porto Alegre, Brazil · Recruiting
Clinical Trial Site
São Paulo, Estado de Bahia, Brazil · Recruiting
Clinical Trial Site
Fortaleza, Paraná, Brazil · Recruiting
Clinical Trial Site
Barretos, São Paulo, Brazil · Recruiting
Showing 40 of 173 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.